SINOVAC's CoronaVac® Answers Hong Kong's Need for Self-Pay COVID-19 Vaccines

Sinovac Biotech Ltd. , a leading provider of biopharmaceutical products in China, today announced it will provide its inactivated COVID-19 vaccine, CoronaVac® , to self-paying groups in Hong... | May 10, 2023

Related Keywords

Hong Kong ,Beijing ,China ,University Of Hong Kong ,Hong Kong General ,United States ,Weidong ,Anhui ,America ,Chinese ,Helen Yang ,Sinovac Biotech Ltd ,World Health Organization Emergency Use List ,World Health Organization Emergency Use List Procedure ,Sinovac Biotech ,Hong Kong Special Administrative Region ,Yin Weidong ,World Health Organization ,Emergency Use ,Chief Business Officer ,Lau Chak Sing ,Hong Kong Vaccine Advisory Expert Committee ,Emergency Use List Procedure ,Gleneagles Hospital ,Poisons Ordinance Cap ,Sinovac Biotech Ltd Stock Exchange ,News ,Information ,Press Release ,Sinovac ,Biotech ,Reading ,Provider ,F ,Iopharmaceutical ,Products ,N ,Oday ,Nnounced ,It ,Hill ,Rovide ,Its ,Inactivated ,O ,Groups ,N Sva Agp8696w1045 ,